All Stocks
A

AVBP

ArriVent BioPharma, Inc. Common Stock
Healthcare›Biotechnology|NASDAQ Global Market|US

Price

$24.89

Market Cap

$1.10B

Beta

0.86

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%
EPS Growth (YoY)-87.03%
Revenue CAGR 3Y+0.00%
P/E Ratio0.0
PEG Ratio—
FCF Yield-14.60%
Debt / Equity0.00
Interest Coverage999.0x

Sign up free to unlock full analysis

  • ✓Full 24-factor quality scorecard
  • ✓AI investment committee analysis
  • ✓Factor radar & value trap detection
  • ✓10-year strategy backtesting
  • ✓Advanced screening & filtering
Get started free

No credit card required

Already have an account? Sign in to view the full analysis for AVBP.

AVBP — ArriVent BioPharma, Inc. Common Stock Stock Analysis | Tessera Alpha